Hudson Executive Capital LP Diversified Active

CIK: 0001652522 · Show all filings

Period: Q4 2017 (← Previous) (Next →)

Filing Date: Feb 14, 2018

Total Value ($000): $208,286 (100.0% shares, 0.0% debt)

Holdings (7)

EGRX EAGLE PHARMACEUTICALS INC 24.9%

Value ($000) $51,871 Shares 971,000 Est. Cost $46.78 Unrealized +19.0%

— CIT GROUP INC 20.1%

Value ($000) $41,922 Shares 851,557 Est. Cost $37.71 Unrealized —

ATRC ATRICURE INC 17.6%

Value ($000) $36,582 Shares 2,005,610 Est. Cost $17.31 Unrealized +14.4%

— CARDTRONICS PLC 17.3%

Value ($000) $36,034 Shares 1,945,655 Est. Cost $18.52 Unrealized —

— ACORDA THERAPEUTICS INC 13.6%

Value ($000) $28,243 Shares 1,316,700 Est. Cost $20.62 Unrealized —

— CORINDUS VASCULAR ROBOTICS I 5.5%

Value ($000) $11,450 Shares 11,336,154 Est. Cost $1.31 Unrealized —

— FCB FINL HLDGS INC 1.0%

Value ($000) $2,184 Shares 43,000 Est. Cost $50.79 Unrealized —

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
EGRX	EAGLE PHARMACEUTICALS INC	971,000	$51,871	24.9%	$46.78	+19.0%	COM	269796108
—	CIT GROUP INC	851,557	$41,922	20.1%	$37.71	—	COM NEW	125581801
ATRC	ATRICURE INC	2,005,610	$36,582	17.6%	$17.31	+14.4%	COM	04963C209
—	CARDTRONICS PLC	1,945,655	$36,034	17.3%	$18.52	—	SHS CL A	G1991C105
—	ACORDA THERAPEUTICS INC	1,316,700	$28,243	13.6%	$20.62	—	COM	00484M106
—	CORINDUS VASCULAR ROBOTICS I	11,336,154	$11,450	5.5%	$1.31	—	COM	218730109
—	FCB FINL HLDGS INC	43,000	$2,184	1.0%	$50.79	—	CL A	30255G103